OZENOXACIN - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for ozenoxacin and what is the scope of freedom to operate?
Ozenoxacin
is the generic ingredient in one branded drug marketed by Ferrer Internacional and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Ozenoxacin has thirty-seven patent family members in twenty-three countries.
There is one drug master file entry for ozenoxacin.
Summary for OZENOXACIN
International Patents: | 37 |
US Patents: | 2 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 53 |
Clinical Trials: | 2 |
Patent Applications: | 136 |
What excipients (inactive ingredients) are in OZENOXACIN? | OZENOXACIN excipients list |
DailyMed Link: | OZENOXACIN at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for OZENOXACIN
Generic Entry Date for OZENOXACIN*:
Constraining patent/regulatory exclusivity:
Dosage:
CREAM;TOPICAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for OZENOXACIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ferrer Internacional S.A. | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for OZENOXACIN
US Patents and Regulatory Information for OZENOXACIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ferrer Internacional | XEPI | ozenoxacin | CREAM;TOPICAL | 208945-001 | Dec 11, 2017 | DISCN | Yes | No | 9,399,014 | ⤷ Subscribe | ⤷ Subscribe | ||||
Ferrer Internacional | XEPI | ozenoxacin | CREAM;TOPICAL | 208945-001 | Dec 11, 2017 | DISCN | Yes | No | 9,180,200 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OZENOXACIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ferrer Internacional | XEPI | ozenoxacin | CREAM;TOPICAL | 208945-001 | Dec 11, 2017 | 6,335,447 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OZENOXACIN
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Cyprus | 1114838 | ⤷ Subscribe | |
Brazil | PI0920355 | composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina | ⤷ Subscribe |
European Patent Office | 2570117 | Compositions pharmaceutiques topiques (Pharmaceutical topical compositions) | ⤷ Subscribe |
China | 102186460 | Pharmaceutical topical compositions | ⤷ Subscribe |
Taiwan | 201511779 | Pharmaceutical topical compositions comprising ozenoxacin and uses of the same | ⤷ Subscribe |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for OZENOXACIN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2344130 | 1790031-7 | Sweden | ⤷ Subscribe | PRODUCT NAME: OZENOXACIN; NAT. REG. NO/DATE: 54608 20170622; FIRST REG.: BE ES/H/414/01/DC 20170519 |
2344130 | C201730036 | Spain | ⤷ Subscribe | PRODUCT NAME: OZENOXACINO; NATIONAL AUTHORISATION NUMBER: 82357-ES/H/0414/001/DC; DATE OF AUTHORISATION: 20170830; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): ES/H/414/01/DC; DATE OF FIRST AUTHORISATION IN EEA: 20170519 |
2344130 | 300884 | Netherlands | ⤷ Subscribe | PRODUCT NAME: OZENOXACIN; REGISTRATION NO/DATE: ES/H/414/1/DC 20170519 |
2344130 | 132017000093887 | Italy | ⤷ Subscribe | PRODUCT NAME: OZENOXACIN(DUBINE); AUTHORISATION NUMBER(S) AND DATE(S): ES/H/414/01/DC, 20170519;045237017, 20170711 |
2344130 | 2017C/031 | Belgium | ⤷ Subscribe | PRODUCT NAME: OZENOXACINE; AUTHORISATION NUMBER AND DATE: BE509591 20170519 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
OZENOXACIN Market Analysis and Financial Projection Experimental
More… ↓